Abstract
Objectives
Although there have been several reports that described characteristics for young age stroke, information regarding very young age (18–30 years old) has been limited. We aimed to analyze demographic factors, stroke subtype, and 3-month outcome in acute ischemic stroke patient who have relatively very young age in multicenter stroke registry.
Methods
We evaluated all 122 (7.1%) consecutive acute ischemic stroke (within 7 days after symptom onset) patients aged 18 to 30 from 17,144 patients who registered in multicenter prospective stroke registry, 1997 to 2012. Etiology was classified by Trial of Org 10172 in Acute Stroke Treatment criteria. Stroke severity was defined as National Institutes of Health Stroke Scale (NIHSS) and stroke outcome was defined by modified Rankin scale (mRS) at 3 months after index stroke.
Results
The mean age of all included patients was 25.1±3.7 years and 76 patients (62.2%) were male. The median NIHSS at admission was 4. Considering stroke subtype, 37 patients (30.3%) had stroke of other determined etiology (SOD), 37 (30.3%) had undetermined negative evaluation (UN) and 31 (25.4%) had cardioembolism (CE) were frequently noted. After adjusting age, sex and variables which had P<0.1 in univariable analysis (NIHSS and stroke subtype), CE stroke subtype (odds ratio, 4.68; 95% confidence interval, 1.42–15.48; P=0.011) were significantly associated with poor functional outcome (mRS≥3).
References
1. Kristensen B, Malm J, Carlberg B, Stegmayr B, Backman C, Fagerlund M, et al. Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke. 1997; 28:1702–1709.
2. Carolei A, Marini C, Ferranti E, Frontoni M, Prencipe M, Fieschi C. A prospective study of cerebral ischemia in the young: analysis of pathogenic determinants. The National Research Council Study Group. Stroke. 1993; 24:362–367.
3. Siqueira Neto JI, Santos AC, Fabio SR, Sakamoto AC. Cerebral infarction in patients aged 15 to 40 years. Stroke. 1996; 27:2016–2019.
4. Hong KS, Bang OY, Kang DW, Yu KH, Bae HJ, Lee JS, et al. Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the Korean Stroke Society and Clinical Research Center For Stroke. J Stroke. 2013; 15:2–20.
5. Kwon SU, Kim JS, Lee JH, Lee MC. Ischemic stroke in Korean young adults. Acta Neurol Scand. 2000; 101:19–24.
6. Tibæk M, Dehlendorff C, Jørgensen HS, Forchhammer HB, Johnsen SP, Kammersgaard LP. Increasing incidence of hospitalization for stroke and transient ischemic attack in young adults: a registry-based study. J Am Heart Assoc. 2016; 5:e003158.
7. Song TJ, Suh SH, Min PK, Kim DJ, Kim BM, Heo JH, et al. The influence of anti-platelet resistance on the development of cerebral ischemic lesion after carotid artery stenting. Yonsei Med J. 2013; 54:288–294.
8. Lee BI, Nam HS, Heo JH, Kim DI. Yonsei Stroke Team. Yonsei Stroke Registry: analysis of 1,000 patients with acute cerebral infarctions. Cerebrovasc Dis. 2001; 12:145–151.
9. Song TJ, Cho HJ, Chang Y, Choi K, Jung AR, Youn M, et al. Low plasma proportion of omega 3-polyunsaturated fatty acids predicts poor outcome in acute non-cardiogenic ischemic stroke patients. J Stroke. 2015; 17:168–176.
10. Lee BC, Hwang SH, Jung S, Yu KH, Lee JH, Cho SJ, et al. The Hallym Stroke Registry: a web-based stroke data bank with an analysis of 1,654 consecutive patients with acute stroke. Eur Neurol. 2005; 54:81–87.
11. Song TJ, Kim J, Lee HS, Nam CM, Nam HS, Kim YD, et al. Distribution of cerebral microbleeds determines their association with impaired kidney function. J Clin Neurol. 2014; 10:222–228.
12. Hillbom M, Numminen H, Juvela S. Recent heavy drinking of alcohol and embolic stroke. Stroke. 1999; 30:2307–2312.
13. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24:35–41.
14. Provenzale JM, Sarikaya B. Comparison of test performance characteristics of MRI, MR angiography, and CT angiography in the diagnosis of carotid and vertebral artery dissection: a review of the medical literature. AJR Am J Roentgenol. 2009; 193:1167–1174.
15. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology. 1997; 49:1541–1545.
16. Putaala J, Metso AJ, Metso TM, Konkola N, Kraemer Y, Haapaniemi E, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009; 40:1195–1203.
17. Ghandehari K, Moud ZI. Incidence and etiology of ischemic stroke in Persian young adults. Acta Neurol Scand. 2006; 113:121–124.
18. Rubinstein SM, Peerdeman SM, van Tulder MW, Riphagen I, Haldeman S. A systematic review of the risk factors for cervical artery dissection. Stroke. 2005; 36:1575–1580.
19. Debette S, Compter A, Labeyrie MA, Uyttenboogaart M, Metso TM, Majersik JJ, et al. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol. 2015; 14:640–654.
20. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke. 2001; 32:2559–2566.
21. Onwuchekwa AC, Onwuchekwa RC, Asekomeh EG. Stroke in young Nigerian adults. J Vasc Nurs. 2009; 27:98–102.
22. Durey A, Bae SM, Lee HJ, Nah SY, Kim M, Baek JH, et al. Carriage rates and serogroups of Neisseria meningitidis among freshmen in a university dormitory in Korea. Yonsei Med J. 2012; 53:742–747.
23. Bodilsen J, Dalager-Pedersen M, Schonheyder HC, Nielsen H. Stroke in community-acquired bacterial meningitis: a Danish population-based study. Int J Infect Dis. 2014; 20:18–22.
24. Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016; 18:2–11.
Table 1.
Table 2.
Variable | Causes for other determined etiology (n=37) |
---|---|
Arterial dissection | 21 (56.8) |
Extracranial internal carotid artery | 8 (21.6) |
Intracranial internal carotid artery* | 1 (2.7) |
Extracranial vertebral artery | 6 (16.2) |
Intracranial vertebral artery | 3 (8.1) |
Middle cerebral artery | 3 (8.1) |
Vasculitis meningitis | 4 (10.8) |
Moyamoya diseases | 4 (10.8) |
Takayasu’s diseases | 3 (8.1) |
Systemic lupus erythematosus | 3 (8.1) |
Sneddon’s syndrome | 1 (2.7) |
Familial protein C, S deficiency | 1 (2.7) |